Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hengrui Therapeutics

Hengrui Therapeutics
PRIVATE STATUS
Corporate LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Operator of a biopharmaceutical company. The company is engaged in the development and commercialization of cancer therapies. Its therapeutic areas of focus are oncology and endocrinology, with multiple clinical-stage assets for oncology/immuno-oncology and diabetes/weight loss.

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 506 Carnegie Center
  • Suite 102
  • Princeton, NJ 08540
  • United States

+1 (609) 000-0000

Hengrui Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Hengrui Therapeutics‘s full profile, request access.

Request full access to PitchBook

Hengrui Therapeutics Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Hengrui Therapeutics‘s full profile, request access.

Request full access to PitchBook

Hengrui Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Adam Zong Ph.D President & Chief Executive Officer